OP09 Anti TNF-α therapy is a major cost driver in...

OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study

M. Van der Valk, M.-J. Mangen, G. Dijkstra, A. van Bodegraven, H. Fidder, D. de Jong, M. Pierik, C.J. van der Woude, M. Romberg-Camps, C. Clemens, J. Jansen, P. van de Meeberg, N. Mahmmod, C. Ponsioen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2012
Language:
english
DOI:
10.1016/s1873-9946(12)60010-5
File:
PDF, 53 KB
english, 2012
Conversion to is in progress
Conversion to is failed